78 related articles for article (PubMed ID: 23696181)
1. Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathy.
Chen YS; Toth I; Danesh-Meyer HV; Green CR; Rupenthal ID
J Pharm Sci; 2013 Jul; 102(7):2322-31. PubMed ID: 23696181
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal injection of lipoamino acid-modified connexin43 mimetic peptide enhances neuroprotection after retinal ischemia.
Chen YS; Green CR; Teague R; Perrett J; Danesh-Meyer HV; Toth I; Rupenthal ID
Drug Deliv Transl Res; 2015 Oct; 5(5):480-8. PubMed ID: 26238242
[TBL] [Abstract][Full Text] [Related]
3. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia.
Chen YS; Green CR; Wang K; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):378-86. PubMed ID: 25497487
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina.
Huang D; Chen YS; Rupenthal ID
Mol Pharm; 2017 Feb; 14(2):533-545. PubMed ID: 27997199
[TBL] [Abstract][Full Text] [Related]
5. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia.
Danesh-Meyer HV; Kerr NM; Zhang J; Eady EK; O'Carroll SJ; Nicholson LF; Johnson CS; Green CR
Brain; 2012 Feb; 135(Pt 2):506-20. PubMed ID: 22345088
[TBL] [Abstract][Full Text] [Related]
6. Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemia.
Danesh-Meyer HV; Huang R; Nicholson LF; Green CR
J Clin Neurosci; 2008 Nov; 15(11):1253-63. PubMed ID: 18824359
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia.
Huang D; Chen YS; Green CR; Rupenthal ID
Biomaterials; 2018 Jun; 168():10-23. PubMed ID: 29597134
[TBL] [Abstract][Full Text] [Related]
8. Peptides and peptide-derived molecules targeting the intracellular domains of Cx43: gap junctions versus hemichannels.
Iyyathurai J; D'hondt C; Wang N; De Bock M; Himpens B; Retamal MA; Stehberg J; Leybaert L; Bultynck G
Neuropharmacology; 2013 Dec; 75():491-505. PubMed ID: 23664811
[TBL] [Abstract][Full Text] [Related]
9. Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury.
O'Carroll SJ; Alkadhi M; Nicholson LF; Green CR
Cell Commun Adhes; 2008 May; 15(1):27-42. PubMed ID: 18649176
[TBL] [Abstract][Full Text] [Related]
10. High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss.
Kerr NM; Johnson CS; Zhang J; Eady EK; Green CR; Danesh-Meyer HV
Exp Neurol; 2012 Mar; 234(1):144-52. PubMed ID: 22226601
[TBL] [Abstract][Full Text] [Related]
11. The use of connexin-based therapeutic approaches to target inflammatory diseases.
O'Carroll SJ; Becker DL; Davidson JO; Gunn AJ; Nicholson LF; Green CR
Methods Mol Biol; 2013; 1037():519-46. PubMed ID: 24029957
[TBL] [Abstract][Full Text] [Related]
12. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening.
Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L
Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825
[TBL] [Abstract][Full Text] [Related]
13. Pressure induces loss of gap junction communication and redistribution of connexin 43 in astrocytes.
Malone P; Miao H; Parker A; Juarez S; Hernandez MR
Glia; 2007 Aug; 55(10):1085-98. PubMed ID: 17551925
[TBL] [Abstract][Full Text] [Related]
14. Response of retinal Connexin43 to optic nerve injury.
Chew SS; Johnson CS; Green CR; Danesh-Meyer HV
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3620-9. PubMed ID: 21310901
[TBL] [Abstract][Full Text] [Related]
15. Protection of retinal ganglion cells against glaucomatous neuropathy by neurotrophin-producing, genetically modified neural progenitor cells in a rat model.
Wang N; Zeng M; Ruan Y; Wu H; Chen J; Fan Z; Zhen H
Chin Med J (Engl); 2002 Sep; 115(9):1394-400. PubMed ID: 12411121
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis of undocked connexin43 gap junction hemichannels in ovarian granulosa cells.
Tong D; Li TY; Naus KE; Bai D; Kidder GM
J Cell Sci; 2007 Nov; 120(Pt 22):4016-24. PubMed ID: 17971414
[TBL] [Abstract][Full Text] [Related]
17. Oculodentodigital dysplasia connexin43 mutations result in non-functional connexin hemichannels and gap junctions in C6 glioma cells.
Lai A; Le DN; Paznekas WA; Gifford WD; Jabs EW; Charles AC
J Cell Sci; 2006 Feb; 119(Pt 3):532-41. PubMed ID: 16418219
[TBL] [Abstract][Full Text] [Related]
18. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
[TBL] [Abstract][Full Text] [Related]
19. Peptidoglycan derived from Staphylococcus epidermidis induces Connexin43 hemichannel activity with consequences on the innate immune response in endothelial cells.
Robertson J; Lang S; Lambert PA; Martin PE
Biochem J; 2010 Nov; 432(1):133-43. PubMed ID: 20815816
[TBL] [Abstract][Full Text] [Related]
20. Cerebral ischemic injury is enhanced in a model of oculodentodigital dysplasia.
Kozoriz MG; Lai S; Vega JL; Sáez JC; Sin WC; Bechberger JF; Naus CC
Neuropharmacology; 2013 Dec; 75():549-56. PubMed ID: 23727526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
